AFYX Therapeutics
AFYX Therapeutics is a clinical stage biopharmaceutical company
AFYX Therapeutics has raised €11M across 1 funding round from 1 investor, most recently a round in Jul 2019. Based in Copenhagen, Denmark; founded 2013; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€11M
€11,423,550
Funding rounds
1
Investors
1
distinct backers
Active since
2019-07
latest 2019-07
Funding by year
EUR raised per yearAFYX Therapeutics — funding by year — interactive chart.
Data table
| AFYX Therapeutics — funding by year | |
|---|---|
| 2019 | €11M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Other | €11M | Sofinnova Partners | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData